Citation: J. Ong et al., DIFFERENTIAL-EFFECTS OF PHOSPHONIC ANALOGS OF GABA ON GABA(B) AUTORECEPTORS IN RAT NEOCORTICAL SLICES, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 408-412
Citation: R. Ravi et al., LONG-TERM FOLLOW-UP OF SURVEILLANCE VERSUS ADJUVANT CHEMOTHERAPY TREATED STAGE-1 NONSEMINOMA PATIENTS, The Journal of urology, 159(5), 1998, pp. 180-180
Citation: J. Ong et al., 3'-IGH ENHANCER ELEMENTS SHIFT SYNERGISTIC INTERACTIONS DURING B-CELLDEVELOPMENT, The Journal of immunology, 160(10), 1998, pp. 4896-4903
Citation: J. Ong et Dib. Kerr, THE GAMMA-AMINOBUTYRIC-ACID UPTAKE INHIBITOR NO-711 POTENTIATES 3-AMINOPROPYLPHOSPHINIC ACID-INDUCED ACTIONS IN RAT NEOCORTICAL SLICES, European journal of pharmacology, 347(2-3), 1998, pp. 197-200
Authors:
RAVI R
ONG J
OLIVER RTD
BADENOCH DF
FOWLER CG
HENDRY WF
Citation: R. Ravi et al., SURGERY AS SALVAGE THERAPY IN CHEMOTHERAPY-RESISTANT NONSEMINOMATOUS GERM-CELL TUMORS, British Journal of Urology, 81(6), 1998, pp. 884-888
Citation: J. Ong et al., ACTIONS OF THIENYL ANALOGS OF BACLOFEN AT GABA(B) RECEPTORS IN RAT NEOCORTICAL SLICES, European journal of pharmacology, 329(2-3), 1997, pp. 133-136
Authors:
STUNTZ M
WILMOTH G
ONG J
STABILE B
STAMOS M
Citation: M. Stuntz et al., USE OF INTRAPERITONEAL 5-FLUOROURACIL AND CHLORHEXIDINE FOR PREVENTION OF RECURRENCE OF PERFORATED COLORECTAL-CARCINOMA IN A RAT MODEL, Diseases of the colon & rectum, 40(9), 1997, pp. 1085-1088
Authors:
RAVI R
OLIVER RTD
ONG J
BADENOCH DF
FOWLER CG
PARIS AMI
HENDRY WF
Citation: R. Ravi et al., A SINGLE-CENTER OBSERVATIONAL STUDY OF SURGERY AND LATE MALIGNANT EVENTS AFTER CHEMOTHERAPY FOR GERM-CELL CANCER, British Journal of Urology, 80(4), 1997, pp. 647-652
Authors:
KERR DIB
ONG J
VACCHER C
BERTHELOT P
FLOUQUET N
VACCHER MP
DEBAERT M
Citation: Dib. Kerr et al., GABA(B) RECEPTOR ANTAGONISM BY RESOLVED (R)-SACLOFEN IN THE GUINEA-PIG ILEUM, European journal of pharmacology, 308(3), 1996, pp. 1-2
Citation: Rtd. Oliver et al., TESTIS CONSERVATION STUDIES IN GERM-CELL CANCER JUSTIFIED BY IMPROVEDPRIMARY CHEMOTHERAPY RESPONSE AND REDUCED DELAY, 1978-1994, British Journal of Urology, 78(1), 1996, pp. 119-124
Authors:
OLIVER RTD
ONG J
OSTROWSKI J
WILLIAMS M
WILTSHIRE C
GALLAGHER CJ
XU J
JACKSON W
BAILEYJOHNSON H
PRATT W
GAMBLE D
MOTT M
TRASK C
Citation: Rtd. Oliver et al., ANGLIAN GERM-CELL CANCER GROUP 3 V 4 COURSES AND 3 V 5 DAY EBCI BEP PILOT-STUDIES FOR METASTATIC NON-SEMINOMA(G2/3) GERM-CELL CANCER/, British Journal of Cancer, 74, 1996, pp. 29-29
Authors:
HARPER P
MACDONALD L
TONG D
ROBINSON A
LAMONT A
TRASK C
JACKSON W
LEVAY J
MANTELL BS
OLIVER RTD
ONG J
XU L
Citation: P. Harper et al., ANGLIAN GERM-CELL CANCER GROUP RANDOMIZED PHASE-2 TOXICITY COMPARISONOF ONE COURSE CARBOPLATIN VERSES RADIOTHERAPY FOR STAGE-1 SEMINOMA, British Journal of Cancer, 74, 1996, pp. 29-29
Authors:
OLIVER RTD
ONG J
XU L
OSTROWSKI MJ
MURRAY P
LEVAY J
WILLIAMS M
Citation: Rtd. Oliver et al., THE ANGLIAN GERM-CELL CANCER GROUP RANDOMIZED PHASE-2 STUDY OF EBCI VEBCA (AUC-5) AND PHASE-1 STUDY OF EBCA (AUC-8) IN METASTATIC NONSEMINOMA, British Journal of Cancer, 74, 1996, pp. 30-30
Citation: Rtd. Oliver et al., COMBINED SEMINOMA NONSEMINOMA SHOULD BE CONSIDERED AS INTERMEDIATE GRADE GERM-CELL CANCER (GCC), European journal of cancer, 31A(9), 1995, pp. 1392-1394
Citation: Rtd. Oliver et al., WEEKLY M-BOP AS A 2ND-LINE AND VIP PLUS HIGH-DOSE AS A 3RD-LINE SALVAGE FOR GERM-CELL CANCER, European journal of cancer, 31A, 1995, pp. 916-916
Citation: C. Boshoff et al., ACCELERATED CISPLATIN-BASED CHEMOTHERAPY FOR ADVANCED BLADDER-CANCER, European journal of cancer, 31A(10), 1995, pp. 1633-1636
Citation: Dib. Kerr et al., O-2-HYDROXY-N-(4-NITROPHENYL)-PROPANESULPHONAMIDE, A NEW CLASS OF GABA(B) RECEPTOR ANTAGONIST IN CENTRAL AND PERIPHERAL PREPARATIONS, European journal of pharmacology, 294(1), 1995, pp. 349-352